Wilmington Investor Network

Tunnel is a developer of cloud-based payment software that facilitates real-time global cross-currency payments without transaction fees. Utilizing distributed ledger technology, Tunnel offers its own payment infrastructure, including application programming interfaces and mobile applications. This innovative approach allows both individuals and companies to conduct transactions securely and efficiently, minimizing costs associated with traditional payment methods while enhancing fraud prevention.

Tunnel is a developer of cloud-based payment software that facilitates real-time global cross-currency payments without transaction fees. Utilizing distributed ledger technology, Tunnel offers its own payment infrastructure, including application programming interfaces and mobile applications. This innovative approach allows both individuals and companies to conduct transactions securely and efficiently, minimizing costs associated with traditional payment methods while enhancing fraud prevention.

Roobrik, Inc. is a company that specializes in providing online assessment and decision-making tools aimed at assisting older adults and their caregivers in navigating health and care choices. Founded in 2013 and headquartered in Greensboro, North Carolina, Roobrik focuses on promoting informed decision-making by offering resources that address critical aspects of later-life care, including driving safety, home safety, and managing conditions like dementia. By simplifying the decision-making process, Roobrik enables families to enhance health and wellness outcomes while potentially reducing costs associated with long-term care.

Respiratory Motion, Inc. is a medical device company headquartered in Waltham, Massachusetts, that specializes in respiratory monitoring systems. Established in 2011, the company focuses on the development and commercialization of innovative devices designed to monitor respiratory variation and vital respiratory parameters. Its flagship product, ExSpiron, is a point-of-care device that non-invasively measures minute ventilation, tidal volume, and respiratory rate, providing physicians with critical data to enhance patient safety and outcomes. Respiratory Motion's technology enables continuous monitoring across diverse patient populations and clinical environments, offering early warnings of potential respiratory collapse. The company's systems have received FDA clearance, underscoring their commitment to advancing respiratory health care.

Meta Materials is a platform technology company that specializes in the invention, design, development, and manufacturing of advanced sustainable materials. The company collaborates with original equipment manufacturers (OEMs) across various industries, utilizing its extensive technology platform that includes holography, lithography, and wireless sensing, all driven by software and artificial intelligence. Meta Materials delivers high-performance solutions for applications in consumer electronics, 5G communications, health and wellness, aerospace, automotive, and clean energy. Its notable products include NANOWEB, a transparent conductive film, as well as holoOPTIX, ARfusion, metaAIR, and glucoWISE, which enable global brands to create innovative and impactful products for their customers.

Avhana Health Inc., established in 2014 and based in Baltimore, Maryland, specializes in streamlining healthcare provider workflows through its application. This platform integrates with electronic health records (EHR) to deliver real-time, patient-specific clinical recommendations, actionable guidelines, and performance metrics directly within the EHR interface. The software facilitates pre-visit planning, suggests relevant orders that can be submitted directly into the EHR, and tracks provider activity for performance evaluation. Avhana Health's mission is to empower healthcare teams with impactful, patient-specific support to enhance care quality and reduce costs.

Validic, Inc. is a technology company specializing in a cloud-based platform that collects and manages mobile health data from various internet-enabled applications and devices. Founded in 2010 and based in Durham, North Carolina, Validic connects healthcare organizations with over 400 clinical and consumer devices, allowing for the integration of patient-recorded data into clinical workflows. Its primary offerings include Validic Solution, which links digital health data to healthcare providers; Validic Connect, which facilitates access to a broader range of clinical and consumer applications; and Validic Mobile, designed for data collection from health apps and in-home devices. The company serves a diverse clientele, including wellness companies, healthcare providers, pharmaceuticals, and health plans, with the goal of enhancing the quality of human life through actionable health data.

Gemmus Pharma Inc., established in 2007 and headquartered in San Francisco, California, is a biotechnology company focused on developing therapeutics for the treatment of influenza and other infectious diseases. The company's primary product candidates are GP1001 and GP1681. GP1001, a non-peptidic eiconsanoid analog, is intended for treating severe influenza infections requiring hospitalization, serving as either a standalone therapy or in combination with antiviral drugs like oseltamivir. Meanwhile, GP1681 aims to alleviate influenza symptoms by moderating the viral-induced cytokine response. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Diseases (NIAID) and plans to submit an Investigational New Drug (IND) application to the FDA for its influenza treatment in 2014.

Trusted Metrics Inc. is an information security company based in Raleigh, North Carolina, founded in 2010. The company specializes in providing a cloud-based security incident and event management platform known as the managed visibility platform, which consolidates data from networking, systems, applications, and security events to enhance enterprise visibility and facilitate rapid response to threats. Its Elastic SOC® platform is designed to serve organizations of all sizes, particularly managed service providers and managed security service providers, by integrating centralized log correlation, intrusion detection, asset and vulnerability management, and threat intelligence into a single console. This solution enables round-the-clock network security monitoring and allows users to track assets, measure security levels, and receive real-time alerts or scheduled reports. Trusted Metrics serves various industries, including local government, higher education, manufacturing, healthcare, and entertainment, and is recognized for its commitment to providing significant visibility into clients' networks. As of July 2018, Trusted Metrics operates as a subsidiary of SolarWinds Worldwide, LLC.

ABK Biomedical Inc. is a Halifax-based company founded in 2012 that specializes in developing embolotherapeutic products aimed at treating conditions such as uterine fibroids, hypervascular tumors, and arteriovenous malformations. The company focuses on enhancing treatment options through innovative biomaterials, particularly by transforming the interventional radiology procedure known as embolization. ABK Biomedical has developed a novel radiopaque microsphere product that serves as a bland embolic agent, emitting beta radiation to improve targeting of tumor vascularity and tissue. This innovation aims to standardize, optimize, and personalize minimally invasive therapies for better patient outcomes.

ChaoLogix, Inc. is a technology company specializing in the development of computing architecture and chipsets. Founded in 2005 and based in Gainesville, Florida, ChaoLogix focuses on creating processors and architecture that leverage chaotic circuit elements. Its innovative Chaologix system is utilized in a variety of applications, including desktop and laptop computers, multimedia and gaming video cards, network routers, and chaotic search engine hardware. Additionally, the company's technology supports smart medical devices, robotics, avionics, satellite systems, and advanced graphics cards. ChaoLogix emphasizes optimal performance and security, designing its semiconductor technology to deter side-channel attacks and enhance data protection. Through its cutting-edge solutions, ChaoLogix aims to address the evolving needs of various sectors, including government and defense.

Gemmus Pharma Inc., established in 2007 and headquartered in San Francisco, California, is a biotechnology company focused on developing therapeutics for the treatment of influenza and other infectious diseases. The company's primary product candidates are GP1001 and GP1681. GP1001, a non-peptidic eiconsanoid analog, is intended for treating severe influenza infections requiring hospitalization, serving as either a standalone therapy or in combination with antiviral drugs like oseltamivir. Meanwhile, GP1681 aims to alleviate influenza symptoms by moderating the viral-induced cytokine response. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Diseases (NIAID) and plans to submit an Investigational New Drug (IND) application to the FDA for its influenza treatment in 2014.

OncoHealth is a company that specializes in the development of screening devices aimed at detecting and diagnosing cancer. Its innovative technology focuses on the creation of protein bio-markers specifically for the screening and diagnostics of cervical cancer and other cancers associated with the human papillomavirus (HPV). By providing advanced tools for medical professionals, OncoHealth enhances the ability to monitor, diagnose, and treat cancer, ultimately contributing to improved patient outcomes in oncology.

Pique Therapeutics, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of therapeutic vaccines for cancer treatment. Founded in 2005, the company aims to become a leader in this field, creating innovative products specifically targeting non-small cell lung, colorectal, head and neck, and pancreatic cancers. By advancing its vaccine technologies, Pique Therapeutics enables physicians to initiate efficient treatment for various cancer types, positioning itself as a key player in the biopharmaceutical landscape.

Basho Technologies, Inc. is a provider of NoSQL database solutions tailored for enterprise-scale applications, particularly for Fortune 50 companies. Founded in 2002 and headquartered in Bellevue, Washington, the company specializes in distributed systems that enable the storage and retrieval of unstructured data while managing active data workloads. Basho's product offerings include the Basho data platform, which supports distributed big data and IoT applications, and various NoSQL databases such as Riak KV, which features multi-cluster replication, and Riak TS, designed for time series data management. Additionally, Basho provides Riak S2, an object storage solution for cloud environments, and various add-ons that enhance data synchronization and real-time analytics capabilities. The company also offers implementation, training, and custom services across multiple industries, including gaming, healthcare, retail, telecommunications, and technology. Basho Technologies, Inc. was previously known as Basho Strategies Inc. before rebranding in 2008.

Basho Technologies, Inc. is a provider of NoSQL database solutions tailored for enterprise-scale applications, particularly for Fortune 50 companies. Founded in 2002 and headquartered in Bellevue, Washington, the company specializes in distributed systems that enable the storage and retrieval of unstructured data while managing active data workloads. Basho's product offerings include the Basho data platform, which supports distributed big data and IoT applications, and various NoSQL databases such as Riak KV, which features multi-cluster replication, and Riak TS, designed for time series data management. Additionally, Basho provides Riak S2, an object storage solution for cloud environments, and various add-ons that enhance data synchronization and real-time analytics capabilities. The company also offers implementation, training, and custom services across multiple industries, including gaming, healthcare, retail, telecommunications, and technology. Basho Technologies, Inc. was previously known as Basho Strategies Inc. before rebranding in 2008.

Sensory Analytics, LLC specializes in developing advanced sensory solutions for measuring coating thickness, color, and process control across various industries, including aerospace, automotive, coatings, electronics, packaging, medical, and pharmaceuticals. The company's flagship products, the SpecMetrix systems, provide real-time and precise measurement of coating and film layer thickness, capable of delivering data with nanometric accuracy down to sub-micron levels. These systems facilitate both in-process and offline measurements, offering flexibility for use on production floors or in laboratory settings. By utilizing non-contact technology, Sensory Analytics enables manufacturers to optimize their coating processes, enhance product quality, and ultimately reduce costs. Founded in 2004 and headquartered in Greensboro, North Carolina, Sensory Analytics is recognized for its innovative contributions to quality assurance and production control.

Consolidated Asset Recovery Systems is a software company based in Raleigh, North Carolina, specializing in solutions for the repossession and remarketing industry. Founded in 2005 by Steve Norwood and Terry Groves, the company develops Internet Based Electronic Asset Management (IBEAM) technology to track and recover assets for banks and dealers. Its services include repossession management, electronic invoicing, skip tracing, audits, legal demands, automated notices, and field assistance. The company supports a network of recovery agents across the United States and serves lenders, dealers, and repossession/recovery agents. Consolidated Asset Recovery Systems operates offices in California, Texas, Colorado, and Florida, with a team of 50 employees. It is known for its growth and profitability, adhering to compliant service providers and offering both software and services tailored to lenders' needs. The company has been recognized with numerous industry awards.

Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.

Wilmington Pharmaceuticals specializes in the development and out-licensing of patient-friendly, fast-dissolving formulations for established medications. The company focuses on creating simpler and more reliable dosage forms that enhance patient experience. By utilizing a fast-dissolving drug delivery method, Wilmington Pharmaceuticals facilitates rapid product development and commercialization, allowing healthcare organizations to access dependable medications efficiently. Their approach not only minimizes regulatory risks but also maximizes economic opportunities for their licensing partners, making them a valuable ally in the pharmaceutical industry.

Affinergy, LLC is a biotechnology company based in Durham, North Carolina, founded in 2003. It specializes in developing innovative products for diagnostic and research applications that purify, concentrate, and remove cells and proteins from tissues and fluids. The company utilizes a phage display platform to identify peptides that bind selectively to various targets, including drugs and biomaterials. Affinergy's technology includes site-specific biological systems with biofriendly linkers designed to adhere to proteins and cells, facilitating targeted biological responses. Additionally, the company focuses on creating implantable devices that can deliver and retain biologics at the site of surgery, particularly in orthopedic procedures and soft tissue repair. Its patented technologies originated from research at Duke University, and Affinergy has been recognized for its advancements in medical device coatings, receiving the 2005 Innovation of the Year award from Frost & Sullivan.